{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T04:22:35Z","timestamp":1751516555905,"version":"3.41.0"},"reference-count":33,"publisher":"Scientific Scholar","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,2]]},"abstract":"\n Background & objectives:<\/jats:title>\n Platelet concentrate contains a rich cocktail of growth factors that support growth and proliferation of cells. The primary goal of this study was to investigate the safety of platelet lysate (PL) in patients with critical limb ischaemia (CLI) not suitable for standard revascularization. Data on the preliminary efficacy are also presented.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n Seven patients (18-70 yr) with CLI classified in the Rutherford grades 3-5, with history of intermittent claudication for more than eight weeks and were not suitable for standard revascularization, underwent autologous intramuscular injections of PL. These patients were examined physically alongside other parameters such as TcPO2, toe pressure, and ankle brachial index, at baseline and were followed up for 12 months.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n The procedure was well tolerated with no serious adverse or any adverse events reported during follow up. Although not the primary aim of this report, preliminary data showed significant clinical improvement in Rutherford stage, ankle-brachial index and toe pressure which persisted for a year.<\/jats:p>\n <\/jats:sec>\n \n Interpretation & conclusions:<\/jats:title>\n Intramuscular injection of PL was well tolerated with no major adverse events reported in our study participants. With the observed satisfactory safety data, preliminary efficacy data of PL should be further validated.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_1441_19","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T09:22:11Z","timestamp":1659432131000},"page":"273-279","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Safety of autologous intramuscular platelet lysate injections in patients with critical limb ischaemia: A pilot, exploratory study"],"prefix":"10.25259","volume":"155","author":[{"given":"Adwan","family":"Sofia","sequence":"first","affiliation":[{"name":"Cell Therapy Center, University of Jordan, Madaba, Jordan"},{"name":"Department of Medical laboratories, American University of Madaba, Madaba, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AlSmady","family":"Moaath","sequence":"additional","affiliation":[{"name":"Department of Cardiac Vascular Surgery\/General Surgery, Jordan University Hospital, Amman, Madaba, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Al-Qatawneh","family":"Omar","sequence":"additional","affiliation":[{"name":"Department of Cardiac Vascular Surgery\/General Surgery, Jordan University Hospital, Amman, Madaba, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaza","family":"Rand","sequence":"additional","affiliation":[{"name":"Cell Therapy Center, University of Jordan, Madaba, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jafar","family":"Hanan","sequence":"additional","affiliation":[{"name":"Cell Therapy Center, University of Jordan, Madaba, Jordan"},{"name":"Department of Anatomy & Histology, University of Jordan, Madaba, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malkawi","family":"Amir","sequence":"additional","affiliation":[{"name":"Department of Cardiac Vascular Surgery\/General Surgery, Jordan University Hospital, Amman, Madaba, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Awidi","family":"Abdalla","sequence":"additional","affiliation":[{"name":"Cell Therapy Center, University of Jordan, Madaba, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2022,7,30]]},"reference":[{"key":"B1-20241212","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1161\/CIRCULATIONAHA.111.033878","article-title":"Genetics of peripheral artery disease","volume":"125","author":"Leeper","year":"2012","journal-title":"Circulation"},{"key":"B2-20241212","first-page":"98","article-title":"Peripheral arterial disease in the Middle East:Underestimated predictor of worse outcome","volume":"2013","author":"El-Menyar","year":"2013","journal-title":"Glob Cardiol Sci Pract"},{"key":"B3-20241212","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11739-011-0683-7","article-title":"Critical limb ischemia","volume":"6","author":"Gresele","year":"2011","journal-title":"Intern Emerg Med"},{"key":"B4-20241212","first-page":"815902","article-title":"Peripheral arterial disease in patients presenting with acute coronary syndrome in six middle eastern countries","volume":"2011","author":"Al-Thani","year":"2011","journal-title":"Int J Vasc Med"},{"key":"B5-20241212","doi-asserted-by":"crossref","first-page":"284851","DOI":"10.1100\/2012\/284851","article-title":"Polyvascular disease in patients presenting with acute coronary syndrome:Its predictors and outcomes","volume":"2012","author":"Thani","year":"2012","journal-title":"ScientificWorld Journal"},{"key":"B6-20241212","doi-asserted-by":"crossref","first-page":"e11519","DOI":"10.1097\/MD.0000000000011519","article-title":"Prevalence of previously unrecognized peripheral arterial disease in patients undergoing coronary angiography","volume":"97","author":"Saleh","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"B7-20241212","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-0031-1278244","article-title":"Peripheral arterial disease:Epidemiology, natural history, diagnosis and treatment","volume":"16","author":"Dhaliwal","year":"2007","journal-title":"Int J Angiol"},{"issue":"(Suppl 2)","key":"B8-20241212","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/S1078-5884(11)60012-9","article-title":"Chapter V:Diabetic foot","volume":"42","author":"Lep\u00e4ntalo","year":"2011","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"B9-20241212","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1634\/stemcells.2006-0432","article-title":"Mesenchymal stem cells regulate angiogenesis according to their mechanical environment","volume":"25","author":"Kasper","year":"2007","journal-title":"Stem Cells"},{"key":"B10-20241212","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1038\/mt.2014.161","article-title":"Neovascularization capacity of mesenchymal stromal cells from critical limb ischemia patients is equivalent to healthy controls","volume":"22","author":"Gremmels","year":"2014","journal-title":"Mol Ther"},{"key":"B11-20241212","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.actbio.2016.03.002","article-title":"A novel platelet lysate hydrogel for endothelial cell and mesenchymal stem cell-directed neovascularization","volume":"36","author":"Robinson","year":"2016","journal-title":"Acta Biomater"},{"key":"B12-20241212","doi-asserted-by":"crossref","first-page":"532519","DOI":"10.1155\/2012\/532519","article-title":"Platelet-rich plasma peptides:Key for regeneration","volume":"2012","author":"S\u00e1nchez-Gonz\u00e1lez","year":"2012","journal-title":"Int J Pept"},{"key":"B13-20241212","doi-asserted-by":"crossref","first-page":"781857","DOI":"10.1155\/2014\/781857","article-title":"Overview of platelet physiology:Its hemostatic and nonhemostatic role in disease pathogenesis","volume":"2014","author":"Ghoshal","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"B14-20241212","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jvs.2012.03.255","article-title":"Update on clinical trials evaluating the effect of biologic therapy in patients with critical limb ischemia","volume":"56","author":"Powell","year":"2012","journal-title":"J Vasc Surg"},{"key":"B15-20241212","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.ahj.2008.06.025","article-title":"Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia","volume":"156","author":"Matoba","year":"2008","journal-title":"Am Heart J"},{"key":"B16-20241212","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/CIRCULATIONAHA.107.727347","article-title":"Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia","volume":"118","author":"Powell","year":"2008","journal-title":"Circulation"},{"key":"B17-20241212","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12015-018-9809-x","article-title":"Dysfunction of mesenchymal stem cells isolated from metabolic syndrome and type 2 diabetic patients as result of oxidative stress and autophagy may limit their potential therapeutic use","volume":"14","author":"Kornicka","year":"2018","journal-title":"Stem Cell Rev Rep"},{"key":"B18-20241212","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s12015-013-9433-8","article-title":"Mesenchymal stem cells as a treatment for peripheral arterial disease:Current status and potential impact of type II diabetes on their therapeutic efficacy","volume":"9","author":"Yan","year":"2013","journal-title":"Stem Cell Rev Rep"},{"key":"B19-20241212","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-2180-13-47","article-title":"Antimicrobial activity of pure platelet-rich plasma against microorganisms isolated from oral cavity","volume":"13","author":"Drago","year":"2013","journal-title":"BMC Microbiol"},{"key":"B20-20241212","doi-asserted-by":"crossref","first-page":"e107813","DOI":"10.1371\/journal.pone.0107813","article-title":"Plasma components and platelet activation are essential for the antimicrobial properties of autologous platelet-rich plasma:An in vitro study","volume":"9","author":"Drago","year":"2014","journal-title":"PLoS One"},{"key":"B21-20241212","doi-asserted-by":"crossref","first-page":"9318","DOI":"10.1016\/j.biomaterials.2013.08.018","article-title":"The effect of Platelet Lysate on osteoblast proliferation associated with a transient increase of the inflammatory response in bone regeneration","volume":"34","author":"Ruggiu","year":"2013","journal-title":"Biomaterials"},{"key":"B22-20241212","doi-asserted-by":"crossref","first-page":"6630","DOI":"10.1016\/j.actbio.2013.02.003","article-title":"Platelet lysate coating on scaffolds directly and indirectly enhances cell migration, improving bone and blood vessel formation","volume":"9","author":"Leotot","year":"2013","journal-title":"Acta Biomater"},{"key":"B23-20241212","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/jcp.20391","article-title":"Platelet lysates promote mesenchymal stem cell expansion:A safety substitute for animal serum in cell-based therapy applications","volume":"205","author":"Doucet","year":"2005","journal-title":"J Cell Physiol"},{"key":"B24-20241212","doi-asserted-by":"crossref","first-page":"e0121713","DOI":"10.1371\/journal.pone.0121713","article-title":"Leukocyte inclusion within a platelet rich plasma-derived fibrin scaffold stimulates a more pro-inflammatory environment and alters fibrin properties","volume":"10","author":"Anitua","year":"2015","journal-title":"PLoS One"},{"key":"B25-20241212","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3727\/096368910X543376","article-title":"Platelet lysate consisting of a natural repair proteome supports human mesenchymal stem cell proliferation and chromosomal stability","volume":"20","author":"Crespo-Diaz","year":"2011","journal-title":"Cell Transplant"},{"key":"B26-20241212","doi-asserted-by":"crossref","first-page":"e7465","DOI":"10.7717\/peerj.7465","article-title":"The effect of platelet lysate in culture of PDLSCs:An in vitro comparative study","volume":"7","author":"Abuarqoub","year":"2019","journal-title":"PeerJ"},{"key":"B27-20241212","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13287-018-0863-8","article-title":"Human platelet lysate in mesenchymal stromal cell expansion according to a GMP grade protocol:A cell factory experience","volume":"9","author":"Becherucci","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"B28-20241212","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40634-017-0113-5","article-title":"The use of lumbar epidural injection of platelet lysate for treatment of radicular pain","volume":"4","author":"Centeno","year":"2017","journal-title":"J Exp Orthop"},{"key":"B29-20241212","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/JSM.0000000000000166","article-title":"Safety and efficacy of autologous intra-articular platelet lysates in early and intermediate knee osteoarthrosis in humans:A prospective open-label study","volume":"25","author":"Al-Ajlouni","year":"2015","journal-title":"Clin J Sport Med"},{"key":"B30-20241212","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13018-016-0349-2","article-title":"Autologous platelet lysate local injections for the treatment of refractory lateral epicondylitis","volume":"11","author":"Tan","year":"2016","journal-title":"J Orthop Surg Res"},{"key":"B31-20241212","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1111\/j.1537-2995.2005.00600.x","article-title":"Tissue regeneration and in loco administration of platelet derivatives:Clinical outcome, heterogeneous products, and heterogeneity of the effector mechanisms","volume":"45","author":"Borzini","year":"2005","journal-title":"Transfusion"},{"key":"B32-20241212","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.2337\/diacare.24.8.1476","article-title":"Platelet dysfunction in type 2 diabetes","volume":"24","author":"Vinik","year":"2001","journal-title":"Diabetes Care"},{"key":"B33-20241212","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000371504","article-title":"Determining the effect of preparation and storage:An effort to streamline platelet components as a source of growth factors for clinical application","volume":"42","author":"Sonker","year":"2015","journal-title":"Transfus Med Hemother"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/ijmr.IJMR_1441_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:04:53Z","timestamp":1751497493000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/safety-of-autologous-intramuscular-platelet-lysate-injections-in-patients-with-critical-limb-ischaemia-a-pilot-exploratory-study\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_1441_19","relation":{},"ISSN":["0971-5916","0975-9174"],"issn-type":[{"type":"print","value":"0971-5916"},{"type":"electronic","value":"0975-9174"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"2019-08-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}